Monthly check-ins with your provider are built into the ongoing treatment structure
Most studies show there is short term benefit of a few weeks to months, but the recurrence rate of symptoms is high (Rasmussen et al., Scand J Rheumatol , 1985
When additional therapy is required, NICE recommends considering a GLP-1 receptor agonist (such as Rybelsus) if the patient has a BMI of 35 kg/m or higher (or 32.5 kg/m or higher for people of South Asian or related ethnicity) and specific psychological or medical problems associated with obesity, or if BMI is lower but insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities
During the first week on GLP-1, you may need to eat by routine instead of appetite
Both semaglutide and tirzepatide act on glucagon-like peptide-1 (GLP-1) receptor agonists in the body
The Real Benefits of GLP-1 Weight Loss Medications The benefits of GLP-1 medications extend well beyond the scale